This article is a correction to:
The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus
Yuyan Dong
Juxiang Liu2†- 1Clinical Medical College, Ningxia Medical University, Yinchuan, China
- 2Department of Endocrinology, Gansu Provincial Hospital, Lanzhou, China
- 3The First Clinical Medical College, Lanzhou University, Lanzhou, China
- 4The First Clinical Medical College, Gansu University of Chinese Medicine, Lanzhou, China
A Corrigendum on
The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus
. by Dong Y, Liu J, Ma J, Quan J, Bao Y and Cui Y (2022). Front. Endocrinol. 13:963191. doi: 10.3389/fendo.2022.963191
In the published article, there was an error in Table 1 as published. The p-value for the Disease course in Table 1 is written as 1000, which should have been recorded as 1.000, as in the original data submitted. The corrected Table 1 and its caption **General information of the Control group, the T2DM group, and the CAS group appear below.
TABLE 1
Table 1 General information of the Control group, the T2DM group, and the CAS group.
In the published article, there was an error in Figure 2 as published. In the scatter plot of GRB2 and FPG, the unit of FPG is written as ng/ml instead of mmol/l. The corrected Figure 2 and its caption **Scatter plots showing the correlation between serum GRB2 concentrations and (a)CIMT, (b)HDL-C, (c)IL-6, (d)HBA1c, (e)FPG, and (f)HOMA-IR in subjects appear below.
FIGURE 2
Figure 2 Scatter plots showing the correlation between serum GRB2 concentrations and (A) CIMT, (B) HDL-C, (C) IL-6, (D) HBA1c, (E) FPG, and (F) HOMA-IR in subjects.
In the published article, there was an error. DBP was erroneously included within the text.
A correction has been made to Results, Correlation of T2DM combined CAS with various factors, Paragraph Number 1. This sentence previously stated:
“A univariate logistic regression analysis indicated that disease duration, WHR, SBP, TG, HDL-C, HBA1c, DBP, FPG, HOMA-IR, IL-6, Hs-CRP, and GRB2 independently associated with T2DM is combined with CAS(P<0.05)”
The corrected sentence appears below:
“A univariate logistic regression analysis indicated that disease duration, WHR, SBP, TG, HDL-C, HBA1c, FPG, HOMA-IR, IL-6, Hs-CRP, and GRB2 independently associated with T2DM is combined with CAS(P<0.05)”
The authors apologize for these error and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: serum GRB2 levels, inflammatory, glycolipid metabolism, type 2 diabetes mellitus, carotid atherosclerosis
Citation: Dong Y, Liu J, Ma J, Quan J, Bao Y and Cui Y (2022) Corrigendum: The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus. Front. Endocrinol. 13:1046738. doi: 10.3389/fendo.2022.1046738
Received: 17 September 2022; Accepted: 04 October 2022;
Published: 21 October 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Dong, Liu, Ma, Quan, Bao and Cui. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jinxing Quan, quanxt@sina.com
†These authors have contributed equally to this work